Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, August 25, 2021
[ Wed, Aug 25th 2021
] - WOPRAI
[ Wed, Aug 25th 2021
] - WOPRAI
[ Wed, Aug 25th 2021
] - WOPRAI
[ Wed, Aug 25th 2021
] - WOPRAI
[ Wed, Aug 25th 2021
] - WOPRAI
[ Wed, Aug 25th 2021
] - WOPRAI
[ Wed, Aug 25th 2021
] - WOPRAI
[ Wed, Aug 25th 2021
] - WOPRAI
[ Wed, Aug 25th 2021
] - WOPRAI
[ Wed, Aug 25th 2021
] - WOPRAI
[ Wed, Aug 25th 2021
] - WOPRAI
[ Wed, Aug 25th 2021
] - WOPRAI
[ Wed, Aug 25th 2021
] - WOPRAI
[ Wed, Aug 25th 2021
] - WOPRAI
[ Wed, Aug 25th 2021
] - WOPRAI
[ Wed, Aug 25th 2021
] - WOPRAI
[ Wed, Aug 25th 2021
] - WOPRAI
[ Wed, Aug 25th 2021
] - WOPRAI
Tue, August 24, 2021
[ Tue, Aug 24th 2021
] - WOPRAI
[ Tue, Aug 24th 2021
] - WOPRAI
[ Tue, Aug 24th 2021
] - WOPRAI
[ Tue, Aug 24th 2021
] - WOPRAI
[ Tue, Aug 24th 2021
] - WOPRAI
[ Tue, Aug 24th 2021
] - WOPRAI
[ Tue, Aug 24th 2021
] - WOPRAI
[ Tue, Aug 24th 2021
] - WOPRAI
[ Tue, Aug 24th 2021
] - WOPRAI
[ Tue, Aug 24th 2021
] - WOPRAI
Oren Livnat Maintained (CARA) at Strong Buy with Increased Target to $35 on, Aug 24th, 2021
Oren Livnat of HC Wainwright & Co., Maintained "Cara Therapeutics, Inc." (CARA) at Strong Buy with Increased Target from $33 to $35 on, Aug 24th, 2021.
Oren has made no other calls on CARA in the last 4 months.
There are 2 other peers that have a rating on CARA. Out of the 2 peers that are also analyzing CARA, 1 agrees with Oren's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Jessica Fye of "JP Morgan" Initiated at Hold and Held Target at $16 on, Tuesday, August 3rd, 2021
This is the rating of the analyst that currently disagrees with Oren
- Joseph Stringer of "Needham" Maintained at Strong Buy with Decreased Target to $26 on, Thursday, April 29th, 2021
